• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4646952)   Today's Articles (45)   Subscriber (50691)
For: Reichard CA, Stephenson AJ, Klein EA. Molecular markers in urologic oncology: prostate cancer. Curr Opin Urol 2016;26:225-30. [DOI: 10.1097/mou.0000000000000273] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Number Cited by Other Article(s)
1
Mian OY, Tendulkar RD, Abazeed ME. The evolving role of molecular profiling in prostate cancer: basal and luminal subtyping transcends tissue of origin. Transl Cancer Res 2017;6:S1441-S1445. [PMID: 30873354 DOI: 10.21037/tcr.2017.10.49] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
2
Irani J. [The pathologist, urologist's air traffic controller]. Ann Pathol 2017. [PMID: 28623963 DOI: 10.1016/j.annpat.2017.05.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
3
Clinical and molecular rationale to retain the cancer descriptor for Gleason score 6 disease. Nat Rev Urol 2016;14:59-64. [DOI: 10.1038/nrurol.2016.240] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA